NCT02020629View on ClinicalTrials.gov

Study on Lixisenatide and Counterregulation to Hypoglycemia

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2015

Conditions
Type 2 Diabetes
Interventions
DRUG

Lixisenatide

Lixisenatide is given for 6 weeks whereafter a hypoglycemia clamp is undertaken

Trial Locations (1)

20502

Clinical Research Department, Malmo

All Listed Sponsors
lead

Lund University

OTHER

NCT02020629 - Study on Lixisenatide and Counterregulation to Hypoglycemia | Biotech Hunter | Biotech Hunter